Excellent 10-Year Outcomes After Early Treat-to-Target in Rheumatoid Arthritis

(MedPage Today) -- Most patients with rheumatoid arthritis (RA) whose initial treatment used a stringent treat-to-target strategy in a clinical trial were in remission 10 years later, with only modest radiographic progression over that time, researchers...